DAFNA Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,100	Closed	-$222K	–	91
2022 Q2	$222K	Hold	3,100	–	–	0.06%	85
2022 Q1	$304K	Sell	3,100 -2,500	-45%	-$211K	0.08%	87
2021 Q4	$475K	Hold	5,600	–	–	0.12%	83
2021 Q3	$447K	Hold	5,600	–	–	0.12%	77
2021 Q2	$545K	Hold	5,600	–	–	0.11%	81
2021 Q1	$655K	Sell	5,600 -1,000	-15%	-$117K	0.16%	79
2020 Q4	$734K	Hold	6,600	–	–	0.22%	63
2020 Q3	$784K	Hold	6,600	–	–	0.25%	61
2020 Q2	$747K	Sell	6,600 -7,000	-51%	-$688K	0.22%	67
2020 Q1	$908K	Hold	13,600	–	–	0.38%	54
2019 Q4	$1.24M	Buy	13,600 +7,000	+106%	+$679K	0.43%	54
2019 Q3	$569K	Hold	6,600	–	–	0.21%	67
2019 Q2	$692K	Hold	6,600	–	–	0.26%	64
2019 Q1	$827K	Hold	6,600	–	–	0.36%	58
2018 Q4	$744K	Buy	+6,600	New	+$1.02M	0.37%	54